Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. De Freitas Gonzalez (León, Spain), J. Villegas Alcázar (León, Spain), R. Almeida Cabrera (León, Spain), C. Mier Bango (León, Spain), L. Sierra Herranz (León, Spain), J. Juan García (León, Spain), I. Herráez Ortega (León, Spain), N. Alonso Orcajo (León, Spain), S. García García (León, Spain), E. Bollo De Miguel (León, Spain). Smoking-related intersticial fibrosis (srif): A new entity?. 3031

Member's Comments

No comment yet.

Related content which might interest you: Combined emphysema & interstitial pulmonary disease. A new disease entity? Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002 Combined pulmonary fibrosis and emphysema: A distinct entity? Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Lung fibrosis. An entity unto itself? Source: ERS Research Seminar 2016 Year: 2016 Cystic interstitial lung disease - a rare disease? Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease Year: 2015 Smoking-related interstitial lung diseases: a concise review Source: Eur Respir J 2001; 17: 122-132 Year: 2001 Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Idiopathic non-specific interstitial pneumonia (NSIP): is it an autoimmune clinical entity? Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis? Source: International Congress 2014 – ILDs 1 Year: 2014 Does emphysema coexistence with IPF change prognosis? Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Source: Eur Respir J 2007; 30: 835-839 Year: 2007 Lung inflammation in cystic fibrosis: an overlooked therapeutic target? Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Idiopathic pulmonary fibrosis: a treatable disease? Source: Eur Respir J 2003 Dec 01;22(6):872-873 Year: 2003 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Idiopathic interstitial pneumonias - where is inflammation of relevance? Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases Year: 2004 What’s new in interstitial lung diseases in children? Source: Virtual Congress 2021 – Paediatric year in review Year: 2021